Blog
83 Articles
A Year in Review: 2020
In March 2020, life as we knew it changed. The way we work, the way we gather, the way we each live our daily lives all felt upended, seemingly overnight. The global pandemic of COVID-19 affected everything, including cancer care and research. COVID-19 brought new risks to cancer patients, whose immune systems are compromised from […]
Multi-Site Precision Promise Study Opens
Dr. Vincent Picozzi explains how Precision Promise clinical trial will use a personalized approach for pancreatic cancer patients.
AACR Virtual Special Conference on Pancreatic Cancer: Day Two Highlights
Let’s Win and the Lustgarten Foundation present highlights of Day Two of the AACR Virtual Special Conference on Pancreatic Cancer.
AACR Virtual Special Conference on Pancreatic Cancer: Day One Highlights
Let’s Win and the Lustgarten Foundation present highlights of Day One of the AACR Virtual Special Conference on Pancreatic Cancer.
Navigating Pancreatic Cancer: Apps at Your Fingertips
Manage your pancreatic cancer care effectively with these seven smartphone apps. Track your nutrition intake, doctor’s appointments, and more.
GENERATE Trial Expands Eligibility
Dr. Sapna Syngal explains the expanded eligibility standards for the GENERATE Study for genetic testing of pancreatic cancer patients and relatives.
DIRECT Study Focuses on NanoKnife Technology
Dr. Daniel Holzwanger is part of the NanoKnife irreversible electroporation (IRE) study for stage III pancreatic cancer patients.
COVID-19 and Pancreatic Cancer Clinical Trials
How is the COVID-19 pandemic affecting clinical trials? Learn more about what steps are being taken to protect patients on trials, plus more.
A Second Opinion: Important for Pancreatic Cancer Patients
Dr. Allyson Ocean and Dr. Jordan Winter explain why getting a second opinion can be of great benefit for pancreatic cancer patients.
Chemotherapy: A Key Player in the Battle Against Pancreatic Cancer
Dr. Gabriela Chiorean walks us through the different types of chemotherapy treatments for pancreatic cancer and how they work.
Looking Back at the Year in Research: 2019
Research highlights of 2019 include: approval of a PARP inhibitor, artificial intelligence to diagnose pancreatic cysts, and updated radiation guidelines.
Study Shows Fungi Boost Pancreatic Cancer Development and Growth
Drs. George Miller and Berk Aykut are leading research into the role of fungi in the growth and development of pancreatic cancer.
For Pancreatic Cancer Patients, Pain Control Through Targeted Radiotherapy
Dr. Yaacov Lawrence is using celiac plexus radiotherapy in a clinical trials to target a source of pain for pancreatic cancer patients.
CAR T Cell Trial Targets Mesothelin
In an immunotherapy clinical trial, Dr. Mark O’Hara is using CAR T cells to attack mesothelin-expressing tumor cells in pancreatic cancer.
Pancreatic Cancer Patients in the UK Benefit From Unique Precision Medicine Project
Dr. David Chang explains the Precision Panc initiative, a program through the UK’s NHS that helps pancreatic cancer patients find treatments.